Aducanumab: The Controversy Over Its Accelerated Approval for Alzheimer’s Disease

This recording of our Spring, 2022 seminar features a presentation by Dr. Barry Greenberg on the topic of aducanuamb. Dr. Greenberg provides a review of drugs currently approved for Alzheimer’s disease, an overview of the FDA approval process and controversial decision on aducanumab, and discusses what we’ve learned and where we’re heading.
This educational program was the result of collaborations between multiple groups at Morgan State University and Johns Hopkins. It was presented by Morgan State University's RCMI, ASCEND, and School of Computer, Mathematical and Natural Sciences, and was co-sponsored by Morgan CARES, the Johns Hopkins Alzheimer’s Disease Research Center, and the Johns Hopkins Alzheimer’s Disease Resource Center for Minority Aging Research.